Family PracticeNursingPediatricsPulmonologyInternal MedicineCritical CareEmergency MedicinePathologyPharmacyPublic HealthVaccinesInfectious DiseaseCoronavirus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Sept. 9, 2020 (HealthDay News) -- A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.
The company is investigating whether the illness may be a side effect of the vaccine, the Associated Press reported. The pause in the study covers the United States and other countries where the vaccine is being tested. The health news site STAT said the possible side effect occurred in the United Kingdom, the AP reported.
"We are working to expedite the review of the single event to minimize any potential impact on the trial timeline," AstraZeneca said in a statement.
Large, final-stage clinical trials of two other COVID-19 vaccines are underway in the United States, one from Moderna and the other from Pfizer and BioNTech. Those two vaccines work differently than the AstraZeneca vaccine, the AP reported.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 25, 2022
Read this Next
Other Trending Articles